Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis

Yamakawa, Natsuko; Yagishita, Naoko; Matsuo, Tomohiro; Yamauchi, Junji; Ueno, Takahiko; Inoue, Eisuke; Takata, Ayako; Nagasaka, Misako; Araya, Natsumi; Hasegawa, Daisuke; Coler-Reilly, Ariella; Tsutsumi, Shuntaro; Sato, Tomoo; Araujo, Abelardo; Casseb, Jorge; Gotuzzo, Eduardo; Jacobson, Steven; Martin, Fabiola; Puccioni-Sohler, Marzia; Taylor, Graham P.; Yamano, Yoshihisa; Japan Clinical Research Group on HAM/TSP

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis

Detalhes bibliográficos
Autor(a) principal:	Yamakawa, Natsuko
Data de Publicação:	2020
Outros Autores:	Yagishita, Naoko, Matsuo, Tomohiro, Yamauchi, Junji, Ueno, Takahiko, Inoue, Eisuke, Takata, Ayako, Nagasaka, Misako, Araya, Natsumi, Hasegawa, Daisuke, Coler-Reilly, Ariella, Tsutsumi, Shuntaro, Sato, Tomoo, Araujo, Abelardo, Casseb, Jorge, Gotuzzo, Eduardo, Jacobson, Steven, Martin, Fabiola, Puccioni-Sohler, Marzia, Taylor, Graham P., Yamano, Yoshihisa, Japan Clinical Research Group on HAM/TSP
Tipo de documento:	Artigo
Idioma:	eng
Título da fonte:	Repositório Institucional da FIOCRUZ (ARCA)
Texto Completo:	https://www.arca.fiocruz.br/handle/icict/43044
Resumo:	Japan Clinical Research Group on HAM/TSP: Takeo Nakayama, Satoshi Kamei, Jun-Ichi Kira, Toshiki Watanabe, Tatsuo Kohriyama, Akihiko Okayama, Atsushi Kawakami, Kenji Yuzawa, Masanori Nakagawa, Tatsufumi Nakamura, Ryuji Kubota, Eiji Matsuura, Koju Kamoi, Takashi Nakajima, Hiroyuki Murai, Kaoru Uchimaru, Yoshio Tsuboi, Yukihiro Namihira, Satoshi Ishihara, Masaaki Niino, Masahiro Nagai, Kunihiko Umekita, Norihiro Takenouchi, Toshio Matsuzaki, Youichi Hokezu, Hideki Nakamura, Takuya Matsushita, Yuji Morio, Hisashi Yonezawa, Takashi Tokashiki, Keiko Tamaki, Hirokuni Sakima, Naoko Yagishita, Tomohiro Matsuo, Junji Yamauchi, Eisuke Inoue, Ayako Takata, Natsumi Araya, Daisuke Hasegawa, Tomoo Sato, Yoshihisa Yamano

Metadados do item

id	CRUZ_4688a38395b7013d1cdf3f2c213de6d2
oai_identifier_str	oai:www.arca.fiocruz.br:icict/43044
network_acronym_str	CRUZ
network_name_str	Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str	2135
spelling	Yamakawa, NatsukoYagishita, NaokoMatsuo, TomohiroYamauchi, JunjiUeno, TakahikoInoue, EisukeTakata, AyakoNagasaka, MisakoAraya, NatsumiHasegawa, DaisukeColer-Reilly, AriellaTsutsumi, ShuntaroSato, TomooAraujo, AbelardoCasseb, JorgeGotuzzo, EduardoJacobson, StevenMartin, FabiolaPuccioni-Sohler, MarziaTaylor, Graham P.Yamano, YoshihisaJapan Clinical Research Group on HAM/TSP2020-08-27T21:57:28Z2020-08-27T21:57:28Z2020YAMAKAWA, Natsuko et al. Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis. Orphanet journal of rare diseases, v. 15, n. 1, p. 1-11, 2020.1750-1172https://www.arca.fiocruz.br/handle/icict/4304410.1186/s13023-020-01451-3Japan Clinical Research Group on HAM/TSP: Takeo Nakayama, Satoshi Kamei, Jun-Ichi Kira, Toshiki Watanabe, Tatsuo Kohriyama, Akihiko Okayama, Atsushi Kawakami, Kenji Yuzawa, Masanori Nakagawa, Tatsufumi Nakamura, Ryuji Kubota, Eiji Matsuura, Koju Kamoi, Takashi Nakajima, Hiroyuki Murai, Kaoru Uchimaru, Yoshio Tsuboi, Yukihiro Namihira, Satoshi Ishihara, Masaaki Niino, Masahiro Nagai, Kunihiko Umekita, Norihiro Takenouchi, Toshio Matsuzaki, Youichi Hokezu, Hideki Nakamura, Takuya Matsushita, Yuji Morio, Hisashi Yonezawa, Takashi Tokashiki, Keiko Tamaki, Hirokuni Sakima, Naoko Yagishita, Tomohiro Matsuo, Junji Yamauchi, Eisuke Inoue, Ayako Takata, Natsumi Araya, Daisuke Hasegawa, Tomoo Sato, Yoshihisa YamanoSt. Marianna University School of Medicine. Institute of Medical Science. Department of Rare Diseases Research. Kawasaki, Japan / Tokai Central Hospital. Department of Neurology. Kakamigahara, Japan.St. Marianna University School of Medicine. Institute of Medical Science. Department of Rare Diseases Research. Kawasaki, Japan.Nagasaki University Graduate School of Biochemical Sciences. Department of Urology. Nagasaki, Japan.St. Marianna University School of Medicine. Institute of Medical Science. Department of Rare Diseases Research. Kawasaki, Japan.St. Marianna University School of Medicine. Department of Medical Informatics. Kawasaki, Japan.St. Marianna University School of Medicine. Department of Medical Informatics. Kawasaki, Japan.St. Marianna University School of Medicine. Department of Preventive Medicine. Kawasaki, Japan.Karmanos Cancer Institute/Wayne State University. Department of Oncology. Detroit, MI, USA / St. Marianna University School of Medicine. Department of Advanced Medical Innovation. Kawasaki, Japan.St. Marianna University School of Medicine. Institute of Medical Science. Department of Rare Diseases Research. Kawasaki, Japan.St. Marianna University School of Medicine. Institute of Medical Science. Department of Rare Diseases Research. Kawasaki, Japan.St. Marianna University School of Medicine. Institute of Medical Science. Department of Rare Diseases Research. Kawasaki, Japan.St. Marianna University School of Medicine. Department of Advanced Medical Innovation. Kawasaki, Japan.St. Marianna University School of Medicine. Institute of Medical Science. Department of Rare Diseases Research. Kawasaki, Japan.Fundação Oswaldo Cruz. Instituto Nacional de Infectologia Evandro Chagas. Laboratório de Pesquisa Clínica em Neuroinfecção. Rio de Janeiro, RJ, Brasil.Institute of Tropical Medicine of São Paulo. Sao Paulo, SP, Brazil.Universidad Peruana Cayetano Heredia. Instituto de Medicina Tropical "Alexander von Humbldt". Lima, Peru.National Institutes of Health. National Institute of Neurological Disorders and Stroke. Neuroimmunology Branch. Viral immunology Section. Bethesda, MD, USA.University of Queensland. Faculty of Medicine. Herston, Australia.Universidade Federal do Estado do Rio de Janeiro. Escola de Medicina e Cirurgia. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brasil.Imperial College London. Department of Medicine. Section of Virology. London, UK.St. Marianna University School of Medicine. Institute of Medical Science. Department of Rare Diseases Research. Kawasaki, Japan / St. Marianna University School of Medicine. Department of Advanced Medical Innovation. Kawasaki, Japan.Background: Urinary dysfunction is one of the main features of human T-cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). However, a comprehensive assessment of the severity is difficult because a standardized assessment measure is unavailable. Therefore, this study aimed to develop a novel symptom score for the assessment of urinary dysfunction in HAM/TSP. We interviewed 449 patients with HAM/TSP using four internationally validated questionnaires for assessment of urinary symptoms (27 question items in total): the International Prostate Symptom Score; the International Consultation on Incontinence Questionnaire-Short Form; the Overactive Bladder Symptom Score; and the Nocturia Quality-of-Life questionnaire. We developed a symptom score based on the data of 322 patients who did not use urinary catheters by selecting question items from questionnaires focused on descriptive statistics, correlation analysis, and exploratory factor analysis. The score distribution, reliability, and validity of the developed score were evaluated. Results: First, 16 questions related to quality of life, situations, or subjective assessment were omitted from the 27 questions. Exploratory factor analysis revealed that the remaining 11 questions pertained to three factors: frequent urination, urinary incontinence, and voiding symptoms. Three questions, which had similar questions with larger factor loading, were deleted. Finally, we selected eight question items for inclusion in the novel score. The score distribution exhibited no ceiling or floor effect. The Cronbach's alpha (0.737) demonstrated reliable internal consistency. The new score comprised two subscales with acceptable factorial validity (inter-factor correlation coefficient, 0.322): storage symptoms (frequent urination plus urinary incontinence) and voiding symptoms. The correlation between each item and the subscales suggested acceptable construct validity. Conclusions: We developed a novel score, the HAM/TSP-Bladder Dysfunction Symptom Score, and demonstrated its reliability and validity. The applicability of this score to patients using catheters should be examined in future research.engBMCCreation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesisinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleBladder dysfunctionHuman T-cell leukemia virus type 1Human T-cell leukemia virus type 1-associated myelopathyNeurogenic bladderUrinary symptom scoreTropical spastic paraparesisinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-83099https://www.arca.fiocruz.br/bitstream/icict/43044/1/license.txt586c046dcfeef936e32f0323bb9a47c0MD51ORIGINALCreation_Abelardo_Araujo_etal_INI_2020.pdfCreation_Abelardo_Araujo_etal_INI_2020.pdfapplication/pdf978839https://www.arca.fiocruz.br/bitstream/icict/43044/2/Creation_Abelardo_Araujo_etal_INI_2020.pdf5bf6f2366f43d1400bd362f28c8d3bb4MD52TEXTCreation_Abelardo_Araujo_etal_INI_2020.pdf.txtCreation_Abelardo_Araujo_etal_INI_2020.pdf.txtExtracted texttext/plain47792https://www.arca.fiocruz.br/bitstream/icict/43044/3/Creation_Abelardo_Araujo_etal_INI_2020.pdf.txt0c4e21f119908ee448febb88bc9d69a8MD53icict/430442020-12-01 22:35:40.965oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352020-12-02T01:35:40Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv	Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
title	Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
spellingShingle	Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis Yamakawa, Natsuko Bladder dysfunction Human T-cell leukemia virus type 1 Human T-cell leukemia virus type 1-associated myelopathy Neurogenic bladder Urinary symptom score Tropical spastic paraparesis
title_short	Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
title_full	Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
title_fullStr	Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
title_full_unstemmed	Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
title_sort	Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis
author	Yamakawa, Natsuko
author_facet	Yamakawa, Natsuko Yagishita, Naoko Matsuo, Tomohiro Yamauchi, Junji Ueno, Takahiko Inoue, Eisuke Takata, Ayako Nagasaka, Misako Araya, Natsumi Hasegawa, Daisuke Coler-Reilly, Ariella Tsutsumi, Shuntaro Sato, Tomoo Araujo, Abelardo Casseb, Jorge Gotuzzo, Eduardo Jacobson, Steven Martin, Fabiola Puccioni-Sohler, Marzia Taylor, Graham P. Yamano, Yoshihisa Japan Clinical Research Group on HAM/TSP
author_role	author
author2	Yagishita, Naoko Matsuo, Tomohiro Yamauchi, Junji Ueno, Takahiko Inoue, Eisuke Takata, Ayako Nagasaka, Misako Araya, Natsumi Hasegawa, Daisuke Coler-Reilly, Ariella Tsutsumi, Shuntaro Sato, Tomoo Araujo, Abelardo Casseb, Jorge Gotuzzo, Eduardo Jacobson, Steven Martin, Fabiola Puccioni-Sohler, Marzia Taylor, Graham P. Yamano, Yoshihisa Japan Clinical Research Group on HAM/TSP
author2_role	author author author author author author author author author author author author author author author author author author author author author
dc.contributor.author.fl_str_mv	Yamakawa, Natsuko Yagishita, Naoko Matsuo, Tomohiro Yamauchi, Junji Ueno, Takahiko Inoue, Eisuke Takata, Ayako Nagasaka, Misako Araya, Natsumi Hasegawa, Daisuke Coler-Reilly, Ariella Tsutsumi, Shuntaro Sato, Tomoo Araujo, Abelardo Casseb, Jorge Gotuzzo, Eduardo Jacobson, Steven Martin, Fabiola Puccioni-Sohler, Marzia Taylor, Graham P. Yamano, Yoshihisa Japan Clinical Research Group on HAM/TSP
dc.subject.en.pt_BR.fl_str_mv	Bladder dysfunction Human T-cell leukemia virus type 1 Human T-cell leukemia virus type 1-associated myelopathy Neurogenic bladder Urinary symptom score Tropical spastic paraparesis
topic	Bladder dysfunction Human T-cell leukemia virus type 1 Human T-cell leukemia virus type 1-associated myelopathy Neurogenic bladder Urinary symptom score Tropical spastic paraparesis
description	Japan Clinical Research Group on HAM/TSP: Takeo Nakayama, Satoshi Kamei, Jun-Ichi Kira, Toshiki Watanabe, Tatsuo Kohriyama, Akihiko Okayama, Atsushi Kawakami, Kenji Yuzawa, Masanori Nakagawa, Tatsufumi Nakamura, Ryuji Kubota, Eiji Matsuura, Koju Kamoi, Takashi Nakajima, Hiroyuki Murai, Kaoru Uchimaru, Yoshio Tsuboi, Yukihiro Namihira, Satoshi Ishihara, Masaaki Niino, Masahiro Nagai, Kunihiko Umekita, Norihiro Takenouchi, Toshio Matsuzaki, Youichi Hokezu, Hideki Nakamura, Takuya Matsushita, Yuji Morio, Hisashi Yonezawa, Takashi Tokashiki, Keiko Tamaki, Hirokuni Sakima, Naoko Yagishita, Tomohiro Matsuo, Junji Yamauchi, Eisuke Inoue, Ayako Takata, Natsumi Araya, Daisuke Hasegawa, Tomoo Sato, Yoshihisa Yamano
publishDate	2020
dc.date.accessioned.fl_str_mv	2020-08-27T21:57:28Z
dc.date.available.fl_str_mv	2020-08-27T21:57:28Z
dc.date.issued.fl_str_mv	2020
dc.type.status.fl_str_mv	info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv	info:eu-repo/semantics/article
format	article
status_str	publishedVersion
dc.identifier.citation.fl_str_mv	YAMAKAWA, Natsuko et al. Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis. Orphanet journal of rare diseases, v. 15, n. 1, p. 1-11, 2020.
dc.identifier.uri.fl_str_mv	https://www.arca.fiocruz.br/handle/icict/43044
dc.identifier.issn.pt_BR.fl_str_mv	1750-1172
dc.identifier.doi.none.fl_str_mv	10.1186/s13023-020-01451-3
identifier_str_mv	YAMAKAWA, Natsuko et al. Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis. Orphanet journal of rare diseases, v. 15, n. 1, p. 1-11, 2020. 1750-1172 10.1186/s13023-020-01451-3
url	https://www.arca.fiocruz.br/handle/icict/43044
dc.language.iso.fl_str_mv	eng
language	eng
dc.rights.driver.fl_str_mv	info:eu-repo/semantics/openAccess
eu_rights_str_mv	openAccess
dc.publisher.none.fl_str_mv	BMC
publisher.none.fl_str_mv	BMC
dc.source.none.fl_str_mv	reponame:Repositório Institucional da FIOCRUZ (ARCA) instname:Fundação Oswaldo Cruz (FIOCRUZ) instacron:FIOCRUZ
instname_str	Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str	FIOCRUZ
institution	FIOCRUZ
reponame_str	Repositório Institucional da FIOCRUZ (ARCA)
collection	Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv	https://www.arca.fiocruz.br/bitstream/icict/43044/1/license.txt https://www.arca.fiocruz.br/bitstream/icict/43044/2/Creation_Abelardo_Araujo_etal_INI_2020.pdf https://www.arca.fiocruz.br/bitstream/icict/43044/3/Creation_Abelardo_Araujo_etal_INI_2020.pdf.txt
bitstream.checksum.fl_str_mv	586c046dcfeef936e32f0323bb9a47c0 5bf6f2366f43d1400bd362f28c8d3bb4 0c4e21f119908ee448febb88bc9d69a8
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5 MD5
repository.name.fl_str_mv	Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv	repositorio.arca@fiocruz.br
_version_	1798324844644794368

Creation and validation of a bladder dysfunction symptom score for HTLV-1-associated myelopathy/tropical spastic paraparesis

Registros relacionados